NCT01629056View on ClinicalTrials.gov

The Contact PVI Study: Use of Tissue Contact Data to Guide Atrial Fibrillation Ablation

PHASE4CompletedINTERVENTIONAL
Enrollment

148

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

February 3, 2014

Conditions
Atrial Fibrillation
Interventions
PROCEDURE

ablation

RF ablation to the left atrium of the heart, guided by ECI-contact information (active arm)

PROCEDURE

RF ablation

RF ablation to the left atrium of the heart, without the use of ECI-contact information (control arm)

Trial Locations (1)

Ox39DU

John Radcliffe Hospital, Headington

All Listed Sponsors
lead

Oxford University Hospitals NHS Trust

OTHER

NCT01629056 - The Contact PVI Study: Use of Tissue Contact Data to Guide Atrial Fibrillation Ablation | Biotech Hunter | Biotech Hunter